blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2257275

EP2257275 - KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.11.2012
Database last updated on 15.06.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
[N/P]
Former [2010/49]For all designated states
Allergan, Inc.
2525 Dupont Drive, T2-7H
Irvine, CA 92612 / US
Inventor(s)01 / FARNES, Eldon Quinn
1260 Anacapa Way
Laguna Beach California 92651 / US
02 / ATTAR, Mayssa
1018 Maertzweiler Drive
Placentia California 92870 / US
03 / SCHIFFMAN, Rhett M.
1843 Temple Hills Drive
Laguna Beach California 92651 / US
04 / CHANG, Chin-ming
11645 Maynard Avenue
Tustin California 92782 / US
05 / GRAHAM, Richard S.
5066 Balsawood
Irvine California 92612 / US
06 / WELTY, Devin F.
37 Tessera Avenue
Foothill Ranch California 92610 / US
 [2010/49]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2011/52]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastraße 4
81925 München / DE
Former [2010/49]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastraße 4
81925 München / DE
Application number, filing date09716497.403.03.2009
[2010/49]
WO2009US35787
Priority number, dateUS20080067925P03.03.2008         Original published format: US 67925 P
US20080096096P11.09.2008         Original published format: US 96096 P
US20080111919P06.11.2008         Original published format: US 111919 P
US2009039613102.03.2009         Original published format: US 396131
[2012/08]
Former [2010/49]US2008006792503.03.2008
US2008009609611.09.2008
US2008011191906.11.2008
US2009039613102.03.2009
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009111418
Date:11.09.2009
Language:EN
[2009/37]
Type: A2 Application without search report 
No.:EP2257275
Date:08.12.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 11.09.2009 takes the place of the publication of the European patent application.
[2010/49]
Type: B1 Patent specification 
No.:EP2257275
Date:28.12.2011
Language:EN
[2011/52]
Search report(s)International search report - published on:EP01.04.2010
ClassificationIPC:A61K9/08, A61K31/14
[2010/49]
CPC:
A61K31/14 (EP,US); A61K31/407 (EP,US); A61K47/02 (EP,US);
A61K47/10 (EP,US); A61K47/12 (EP,US); A61K47/186 (EP,US);
A61K47/38 (EP,US); A61K9/0048 (EP,US); A61P27/02 (EP);
A61P29/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/49]
TitleGerman:KETOROLAC-TROMETHAMIN-ZUSAMMENSETZUNGEN ZUR BEHANDLUNG ODER PRÄVENTION VON SCHMERZ[2010/49]
English:KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN[2010/49]
French:COMPOSITIONS DE KÉTOROLAC TROMÉTHAMINE POUR TRAITER OU PRÉVENIR LES DOULEURS OCULAIRES[2010/49]
Entry into regional phase27.09.2010National basic fee paid 
27.09.2010Designation fee(s) paid 
27.09.2010Examination fee paid 
Examination procedure27.09.2010Examination requested  [2010/49]
31.05.2011Communication of intention to grant the patent
30.09.2011Fee for grant paid
30.09.2011Fee for publishing/printing paid
Divisional application(s)EP11195568.8  / EP2446878
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.05.2011
Opposition(s)01.10.2012No opposition filed within time limit [2012/49]
Fees paidRenewal fee
29.03.2011Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.03.2009
CY28.12.2011
CZ28.12.2011
EE28.12.2011
FI28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
MK28.12.2011
MT28.12.2011
RO28.12.2011
SI28.12.2011
SK28.12.2011
LU03.03.2012
BG28.03.2012
NO28.03.2012
GR29.03.2012
MC31.03.2012
IS28.04.2012
PT30.04.2012
[2014/34]
Former [2014/27]CY28.12.2011
CZ28.12.2011
EE28.12.2011
FI28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
MK28.12.2011
MT28.12.2011
RO28.12.2011
SI28.12.2011
SK28.12.2011
LU03.03.2012
BG28.03.2012
NO28.03.2012
GR29.03.2012
MC31.03.2012
IS28.04.2012
PT30.04.2012
Former [2013/35]CY28.12.2011
CZ28.12.2011
EE28.12.2011
FI28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
MK28.12.2011
MT28.12.2011
RO28.12.2011
SI28.12.2011
SK28.12.2011
BG28.03.2012
NO28.03.2012
GR29.03.2012
MC31.03.2012
IS28.04.2012
PT30.04.2012
Former [2013/29]CY28.12.2011
CZ28.12.2011
EE28.12.2011
FI28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
MK28.12.2011
RO28.12.2011
SI28.12.2011
SK28.12.2011
BG28.03.2012
NO28.03.2012
GR29.03.2012
MC31.03.2012
IS28.04.2012
PT30.04.2012
Former [2013/12]CY28.12.2011
CZ28.12.2011
EE28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
MK28.12.2011
RO28.12.2011
SI28.12.2011
SK28.12.2011
BG28.03.2012
NO28.03.2012
GR29.03.2012
MC31.03.2012
IS28.04.2012
PT30.04.2012
Former [2012/47]CY28.12.2011
CZ28.12.2011
EE28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
RO28.12.2011
SI28.12.2011
SK28.12.2011
BG28.03.2012
NO28.03.2012
GR29.03.2012
MC31.03.2012
IS28.04.2012
PT30.04.2012
Former [2012/37]CY28.12.2011
CZ28.12.2011
EE28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
RO28.12.2011
SI28.12.2011
SK28.12.2011
BG28.03.2012
NO28.03.2012
GR29.03.2012
IS28.04.2012
PT30.04.2012
Former [2012/36]CY28.12.2011
CZ28.12.2011
EE28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
RO28.12.2011
SI28.12.2011
SK28.12.2011
BG28.03.2012
NO28.03.2012
GR29.03.2012
IS28.04.2012
Former [2012/35]CY28.12.2011
CZ28.12.2011
EE28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
SI28.12.2011
BG28.03.2012
NO28.03.2012
GR29.03.2012
IS28.04.2012
Former [2012/34]CY28.12.2011
CZ28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
SI28.12.2011
NO28.03.2012
GR29.03.2012
IS28.04.2012
Former [2012/28]CY28.12.2011
HR28.12.2011
LT28.12.2011
LV28.12.2011
SI28.12.2011
NO28.03.2012
GR29.03.2012
Former [2012/27]HR28.12.2011
LT28.12.2011
LV28.12.2011
SI28.12.2011
NO28.03.2012
GR29.03.2012
Former [2012/24]LT28.12.2011
LV28.12.2011
SI28.12.2011
NO28.03.2012
GR29.03.2012
Former [2012/20]LT28.12.2011
NO28.03.2012
Cited inInternational search[A]EP0524587  (RECORDATI CHEM PHARM [CH]) [A] 1-20* example 3 *;
 [A]WO2005101982  (SUN PHARMACEUTICAL IND LTD [IN], et al) [A] 1-20 * example 1 * * claims 1,4 *;
 [A]WO2006071601  (ROXRO PHARMA INC [US], et al) [A] 1-20 * paragraph [0040] *;
 [A]US2008039398  (OUSLER GEORGE W III [US], et al) [A] 1-20 * example 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.